This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business partnership announcement

Davis Schneider, Emergent BioSolutions Partner

Analysis based on 7 articles · First reported Apr 29, 2026 · Last updated Apr 29, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The partnership between Emergent BioSolutions and Davis Schneider is expected to increase public awareness and potentially the demand for Naloxone, positively impacting Emergent BioSolutions' market position. This initiative also highlights a significant public health issue in Canada, which could lead to broader policy discussions and increased investment in addiction treatment and prevention.

pharmaceuticals healthcare

Davis Schneider, a player for the Toronto Blue Jays, has partnered with Emergent BioSolutions, the manufacturer of Narcan (naloxone) nasal spray, to raise awareness about the drug's ability to reverse opioid overdoses. Schneider's older brother died of an opioid overdose in 2020, motivating him to become a paid spokesperson for the company. The partnership aims to reduce the stigma associated with opioid overdoses and encourage the public to carry naloxone kits, which are available for free in Canada. Data from the Canada — Public Health Agency of Canada and the Canada — Canadian Centre on Substance Abuse Act indicates a severe opioid crisis in Canada, with thousands of deaths that could potentially be prevented by timely naloxone administration. Schneider advocates for naloxone kits to be as readily available in public places as fire extinguishers or first-aid kits.

per
Davis Schneider, a Toronto Blue Jays player, became a paid spokesperson for Emergent BioSolutions to raise awareness about naloxone after his brother died of an opioid overdose.
Importance 90.0 Sentiment 20.0
stock
Emergent BioSolutions, the manufacturer of Narcan (naloxone) nasal spray, partnered with Davis Schneider to promote awareness and availability of naloxone, potentially increasing its market reach and public perception.
Importance 90.0 Sentiment 20.0
govactor
The Canada — Canadian Centre on Substance Abuse Act emphasizes the life-saving potential of naloxone in preventing opioid overdose deaths.
Importance 30.0 Sentiment 0.0
govactor
Importance 0.0 Sentiment 0.0
cnt
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.